Skip to main content

Table 1 Patients and the data types for the cohorts: SEQC, Versteeg, TARGET

From: Predicting clinical outcomes in neuroblastoma with genomic data integration

 

SEQC

Versteeg

TARGET

# of patients

498

88

247

HR=1/HR=0

175/323

36/52

217/30

OS=1/OS=0

105/393

30/58

140/107

EFS=1/EFS=0

183/315

34/54

156/91

MYCN amp. / not amp.

92/401

16/72

68/175

  1. Note that our HR definition is based on Children’s Oncology Group. The number of total patients do not add up to 498 for MYCN amplification label as there is missing data